The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,609
Self-citationThe amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction.
Aggleton, J. P. (1992) · Wiley-Liss eBooks · Cited by 1,536
Activation of memory circuits during cue-elicited cocaine craving.
Grant, S., London, E. D., Newlin, D. B., Villemagne, V. L., Liu, X., Contoreggi, C., Phillips, R. L., Kimes, A. S., & Margolin, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.12040 · Cited by 936
Reinstatement of cocaine-reinforced responding in the rat
de Wit, H., & Stewart, J. (1981) · Psychopharmacology · doi:10.1007/bf00432175 · Cited by 928
Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674
Self-citationDynamics of Drug Dependence: Implications of a Conditioning Theory for Research and Treatment
Wikler, A. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750350005001 · Cited by 648
Myths about the treatment of addiction
O'Brien, C., & Thomas McLellan, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90409-2 · Cited by 512
Opposite Modulation of Cocaine-Seeking Behavior by D 1 - and D 2 -Like Dopamine Receptor Agonists
Self, D. W., Barnhart, W. J., Lehman, D. A., & Nestler, E. J. (1996) · Science · doi:10.1126/science.271.5255.1586 · Cited by 492
The two-state model of receptor activation
Leff, P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88989-0 · Cited by 488
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.
Accili, D., Fishburn, C. S., Drago, J., Steiner, H., Lachowicz, J. E., Park, B. H., Gauda, E. B., Lee, E. J., Cool, M. H., Sibley, D. R., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1945 · Cited by 468
Cited by
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Verdejo-García, A., Lawrence, A. J., & Clark, L. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.11.003 · Cited by 1,422
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,241
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., et al. (2010) · Science · doi:10.1126/science.1197410 · Cited by 1,128
Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
The neuropsychological basis of addictive behaviour
Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00088-1 · Cited by 808
Self-citationPsychomotor stimulant addiction: a neural systems perspective
Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700
Self-citationBDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 574
Self-citationPathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Ito, R., Dalley, J. W., Howes, S. R., Robbins, T. W., & Everitt, B. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-19-07489.2000 · Cited by 442
Self-citationA cannabinoid mechanism in relapse to cocaine seeking
De Vries, T. J., Shaham, Y., Homberg, J. R., Crombag, H., Schuurman, K., Dieben, J., Vanderschuren, L. J. M. J., & Schoffelmeer, A. N. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1151 · Cited by 432
Goodman, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 413
Champagne, F. A., Chretien, P., Stevenson, C. W., Zhang, T. Y., Gratton, A., & Meaney, M. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5322-03.2004 · Cited by 398
Genetics of dopamine receptors and drug addiction: a comprehensive review
Foll, B. L., Gallo, A., Strat, Y. L., Lu, L., & Gorwood, P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 393
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., Gross, C., & Sokoloff, P. (2003) · Nature Medicine · doi:10.1038/nm875 · Cited by 383
Self-citationKreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
Smoking-Induced Ventral Striatum Dopamine Release
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1211 · Cited by 347
Molecular Neurobiology of Drug Addiction
Chao, J., & Nestler, E. J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103730 · Cited by 346
Personality, Addiction, Dopamine: Insights from Parkinson's Disease
Dagher, A., & Robbins, T. W. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.031 · Cited by 340
Dopamine D3Receptors Expressed by All Mesencephalic Dopamine Neurons
Diaz, J., Pilon, C., Le Foll, B., Gros, C., Triller, A., Schwartz, J.-C., & Sokoloff, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08677.2000 · Cited by 326
Self-citationThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence
Heidbreder, C. A., Gardner, E. L., Xi, Z.-X., Thanos, P. K., Mugnaini, M., Hagan, J. J., & Ashby, C. R. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.033 · Cited by 322
Everitt, B. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12644 · Cited by 318
Self-citationNeurobiology of Addiction: Toward the Development of New Therapies
KOOB, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 317
Everitt, B. J., & Robbins, T. W. (2000) · Psychopharmacology · doi:10.1007/s002130000566 · Cited by 306
Self-citationTargeting the dopamine D2receptor in schizophrenia
Seeman, P. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.515 · Cited by 302
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Le Foll, B., & Goldberg, S. R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 291
Di Ciano, P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00235-4 · Cited by 288
Reavill, C., Taylor, S. G., Wood, M. D., Ashmeade, T., Austin, N. E., Avenell, K. Y., Boyfield, I., Branch, C. L., Cilia, J., Coldwell, M. C., et al. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39184-0 · Cited by 287
The persistence of maladaptive memory: Addiction, drug memories and anti-relapse treatments
Milton, A. L., & Everitt, B. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.01.002 · Cited by 279
Self-citationJentsch, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00355-4 · Cited by 278
Heidbreder, C. A., & Newman, A. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05149.x · Cited by 273
Dopamine D3Receptor Antagonism Inhibits Cocaine-Seeking and Cocaine-Enhanced Brain Reward in Rats
Vorel, S. R., Ashby, C. R., Paul, M., Liu, X., Hayes, R., Hagan, J. J., Middlemiss, D. N., Stemp, G., & Gardner, E. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09595.2002 · Cited by 269
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence
Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.018 · Cited by 257
Opiate-like effects of sugar on gene expression in reward areas of the rat brain
Spangler, R., Wittkowski, K. M., Goddard, N. L., Avena, N. M., Hoebel, B. G., & Leibowitz, S. F. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.02.013 · Cited by 255
Cohen, C., Perrault, G., Griebel, G., & Soubrié, P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300541 · Cited by 251
Improving translation of animal models of addiction and relapse by reverse translation
Venniro, M., Banks, M. L., Heilig, M., Epstein, D. H., & Shaham, Y. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0378-z · Cited by 212
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Besson, M., Belin, D., McNamara, R., Theobald, D. E., Castel, A., Beckett, V. L., Crittenden, B. M., Newman, A. H., Everitt, B. J., Robbins, T. W., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.162 · Cited by 143
Self-citationZijlstra, F., Booij, J., van den Brink, W., & Franken, I. H. A. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.11.002 · Cited by 109
Bari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105
“…and the reinforcing properties of drugs and food (Barik and de Beaurepaire 2005; Caine and Koob 1993; Daly and Waddington 1993; Duarte et al. 2003a; Pilla et al. 1999), are mainly located in the nucleus accumbens, cerebellum, olfactory tubercle and islands of Calleja (Bouthenet et al. 1991;…”
BackgroundJentsch, J. D., Roth, R. H., & Taylor, J. R. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26028-7 · Cited by 99
Highfield, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00227-5 · Cited by 81
Claytor, R., Lile, J. A., & Nader, M. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.007 · Cited by 19
Metadata
- Authors
- Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P.
- Venue
- Nature
- Published
- 1999-07
- Volume
- 400
- Issue
- 6742
- Pages
- 371-375
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2036218676
- Cited by
- 565
- References
- 28
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.